XIFIN Executives to Share Insights for Driving 15% Increase in Outpatient and Ancillary Services Profit in Upcoming HFMA Webinar
Recently-promoted COO joins XIFIN CEO and HFMA research lead to discuss how outpatient-specific RCM optimizes operational visibility and revenue versus traditional EHRs. SAN DIEGO, Calif., — April 21, 2021 — In an upcoming Healthcare Financial Management Association (HFMA) member webinar, XIFIN Executive Chairman and CEO Lâle White and Kyle Fetter, recently promoted to chief operating officer at...
XIFIN Innovation Drives Growth in Four Key Business Areas Amid COVID-19 Pandemic
Company executives predict diagnostic volume surge remains through Q1, rise in antibody testing imminent SAN DIEGO, Calif., — January 27, 2021 — Following a year that has redefined the diagnostic laboratory industry and healthcare at large, XIFIN experienced strong growth in four key areas in 2020, with expectations of continued momentum into the new year. This includes expansion into digital...
XIFIN Solutions Recognized by Black Book Research for Four Consecutive Years
Company’s Revenue Cycle Management (RCM) Voted #1 Client Rated Solution by Diagnostic Labs SAN DIEGO, Calif., — November 10, 2020 — 2020 has been a year unlike any other, especially for the healthcare industry. Diagnostic providers, in particular, have faced numerous challenges as they manage a rollercoaster of testing volumes – and associated claims and revenue implications – driven...
XIFIN Launches RPM 12 to Accelerate Workflow and Improve Financial Performance for Diagnostic Providers Amid COVID-19
Expanded Capabilities, Including Advanced Analytics, Client & Patient Portals, and Insurance Discovery Enable More Efficient Management of Revenue Cycles and Collections SAN DIEGO, Calif., - September 30, 2020 – Diagnostic providers across the U.S. are overwhelmed by a high number of testing volumes – on average, 165% of their normal levels – as the country continues to...
XIFIN Executives Expect 15% Increase in Fall COVID-19 Testing Volumes; Seeing Regional Labs Pick Up Overflow from Larger, National Players
Company highlights key factors expected to impact Q4 COVID-19 testing during UBS analyst event SAN DIEGO, Calif., - September 22, 2020 – COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as students go back to school and flu season hits its peak. XIFIN...
XIFIN LIS 7 Helps Laboratories Process Increased Testing Volumes Due to COVID-19 Crisis
New Capabilities, Including Dolbey Fusion Narrate, Drive Increased Productivity and Patient Throughput Amid Surge SAN DIEGO, Calif., — September 11, 2020 — The COVID-19 pandemic has created an overwhelming demand for testing, with laboratories nationwide seeing, on average, testing volumes at 1.6 times their normal levels. This pressure demonstrates the need for technology that not only...
Notal Vision Diagnostic Clinic Implements XIFIN RPM to Improve Claim Accuracy, Timely Reimbursement and Patient Experience
The first ophthalmic home diagnostic services company upgrades revenue cycle management platform to provide a better patient experience and prepare for business growthSAN DIEGO, Calif., — August 19, 2020 — Today, XIFIN has announced a collaboration with Notal Vision Diagnostic Clinic, a leading healthcare provider of ophthalmic remote patient monitoring services, to improve claim...
XIFIN Data Reveals COVID-19 Antibody Testing Volumes Surprisingly Low; Better Payor Coverage Needed to Support Testing Increase
As America returns to work, XIFIN shares update on nationwide COVID-19 testing volume and payor behavior during UBS expert event SAN DIEGO, Calif., — June 29, 2020 — Diagnostic laboratories continue to be a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic. XIFIN CEO Lâle White and Kyle Fetter, Executive Vice...
- 1 of 17
- next ›